The Pharma Letter - Pharmaceuticals - MedicinesPHARMACEUTICALS covers patent-protected prescription medicines, with news relating to drugmakers, their financial  performance, licensing, research and merger & acquisition activities. This also reports on health care markets, patent developments,  legislation, product approvals and delays around the globe, backed by a massive archive from which developments in all these areas can be tracked.

Latest Pharma Letter Articles

Pharmaceutical

features_upload

Pfizer ditches figitumumab in study with erlotinib and gets poor results from Sutent

12 March 2010

It was a bad news day for global behemoth Pfizer yesterday, as the company announced that it

0 Comments

Johnson & Johnson unit calls for re-examination of ceftobiprole, licensed from Basilea, submitted to CHMP

12 March 2010

Janssen-Cilag International NV, a subsidiary of US health care giant Johnson & Johnson, has

0 Comments

Increase in UK R&D spend led by pharma and biotech

12 March 2010

The top one thousand UK companies invested more than £26 billion ($39.26 billion) on developing

0 Comments

BioSante reveals positive leukemia vaccine results, sending the stock soaring

12 March 2010

USA-based BioSante Pharmaceuticals saw its shares leap 17% to $2.00 in early trading yesterday,

0 Comments

US FDA to review safety of long term use of common bisphosphonate osteoporosis drugs

12 March 2010

The US Food and Drug Administration says that it will investigate whether a link exists between

0 Comments

FDA grants orphan status for Bayer’s ciprofloxacin for cystic fibrosis

12 March 2010

German drug major Bayer HealthCare has received an orphan drug designation from the US Food

0 Comments